HRP20100699T1 - Topikalni antibioticki sastav za prevenciju lajmske bolesti - Google Patents

Topikalni antibioticki sastav za prevenciju lajmske bolesti Download PDF

Info

Publication number
HRP20100699T1
HRP20100699T1 HR20100699T HRP20100699T HRP20100699T1 HR P20100699 T1 HRP20100699 T1 HR P20100699T1 HR 20100699 T HR20100699 T HR 20100699T HR P20100699 T HRP20100699 T HR P20100699T HR P20100699 T1 HRP20100699 T1 HR P20100699T1
Authority
HR
Croatia
Prior art keywords
pharmaceutical composition
weight
use according
topical pharmaceutical
composition
Prior art date
Application number
HR20100699T
Other languages
English (en)
Croatian (hr)
Inventor
Huber Gustave
Httenes Uta
Roosens-Von Bidder Caroline
Original Assignee
Ixodes Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ixodes Gmbh filed Critical Ixodes Gmbh
Publication of HRP20100699T1 publication Critical patent/HRP20100699T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HR20100699T 2007-07-25 2008-07-24 Topikalni antibioticki sastav za prevenciju lajmske bolesti HRP20100699T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07113143 2007-07-25
PCT/EP2008/059696 WO2009013331A1 (en) 2007-07-25 2008-07-24 Topical antibiotic composition for the prevention of lyme disease

Publications (1)

Publication Number Publication Date
HRP20100699T1 true HRP20100699T1 (hr) 2011-01-31

Family

ID=39149162

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20100699T HRP20100699T1 (hr) 2007-07-25 2008-07-24 Topikalni antibioticki sastav za prevenciju lajmske bolesti

Country Status (15)

Country Link
US (2) US8710019B2 (de)
EP (1) EP2079441B1 (de)
JP (1) JP2010534221A (de)
AT (1) ATE481964T1 (de)
AU (1) AU2008280131B9 (de)
CA (1) CA2694403C (de)
CY (1) CY1110971T1 (de)
DE (1) DE602008002692D1 (de)
DK (1) DK2079441T3 (de)
ES (1) ES2349906T3 (de)
HR (1) HRP20100699T1 (de)
PL (1) PL2079441T3 (de)
PT (1) PT2079441E (de)
SI (1) SI2079441T1 (de)
WO (1) WO2009013331A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT106679B (pt) 2012-11-27 2015-03-25 Hovione Farmaciencia Sa Formulações tópicas de tetraciclinas, sua preparação e usos
WO2015171225A1 (en) * 2014-05-09 2015-11-12 The Johns Hopkins University Identification of novel anti-persister activity for borrelia burgdorferi
AU2016274949B2 (en) * 2015-06-10 2021-07-15 Dechra Veterinary Products, Llc Injectable antibiotic formulations and use thereof
EP3252470B1 (de) 2016-06-03 2020-07-29 Te?ted Oy Verfahren und fester träger zum nachweis von durch zecken übertragenen mikroben in einer biologischen probe

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2368949A1 (fr) * 1976-11-01 1978-05-26 Procter & Gamble Produit antimicrobien a base d'erythromycine pour le traitement topique des affections acneiques
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
PL335934A1 (en) * 1997-03-31 2000-05-22 Johnson & Johnson Consumer Solvent system of increased penetration into pharmaceutical compounds
US7179475B1 (en) * 1998-12-04 2007-02-20 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US6914051B1 (en) * 2000-06-28 2005-07-05 David M Allen Penetrating antibiotic gel for soft tissue diseases
US6589568B2 (en) * 2001-02-16 2003-07-08 Nurad, Inc. Therapeutic body lotion containing alkali metal hypohalite
JP2005508366A (ja) * 2001-11-06 2005-03-31 マキシム ファーマシューティカルス，インコーポレイテッド 感染性疾患の治療用組成物
US8907153B2 (en) * 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same

Also Published As

Publication number Publication date
US9610244B2 (en) 2017-04-04
SI2079441T1 (sl) 2010-12-31
DK2079441T3 (da) 2010-12-13
PT2079441E (pt) 2010-11-19
US20100130437A1 (en) 2010-05-27
AU2008280131A1 (en) 2009-01-29
CA2694403C (en) 2013-09-24
EP2079441B1 (de) 2010-09-22
AU2008280131B2 (en) 2014-06-26
AU2008280131B9 (en) 2014-11-13
ATE481964T1 (de) 2010-10-15
PL2079441T3 (pl) 2011-02-28
CA2694403A1 (en) 2009-01-29
DE602008002692D1 (de) 2010-11-04
EP2079441A1 (de) 2009-07-22
WO2009013331A1 (en) 2009-01-29
US20140194375A1 (en) 2014-07-10
ES2349906T3 (es) 2011-01-12
AU2008280131A8 (en) 2010-03-04
US8710019B2 (en) 2014-04-29
CY1110971T1 (el) 2015-06-11
JP2010534221A (ja) 2010-11-04

Similar Documents

Publication Publication Date Title
NO20081816L (no) Farmasoytiske sammensetninger inneholdende pregabalin
BR112012011784A2 (pt) "formulações parenterais de derivados de gencitabina".
ME02282B (me) Tretman multiple skleroze lakvinimodom
ES2532948T3 (es) Composición tópica para el tratamiento de queratosis actínica
ECSP11011278A (es) Composición farmacéutica que comprende derivados de glucopiranosil difenilmetano, forma farmacéutica de la misma, procedimiento para su preparación y usos de la misma para el control glucémico mejorado en un paciente.
EP2054405A4 (de) Neue biarylbenzimidazolderivate und pharmazeutische zusammensetzung, die diese enthält
AR061289A1 (es) Composiciones farmaceuticas estabilizadas que comprenden fesoterodina
BR112012010083B8 (pt) Composição farmacêutica tópica de liberação sustentada e uso relacionado
BR0313701A (pt) Composição de emulsão-gel tópica compreendendo diclofenaco sódico
CL2008000439A1 (es) Compuestos derivados de indolina, agonistas del adrenoreceptor alfa2c, composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar la congestion asociada a rinitis, sinusitis, al dolor asociado a neuropatia, inflamacion, artritis
HRP20110349T1 (hr) Nova kombinacijska upotreba spoja sulfonamida u liječenju karcinoma
HRP20140132T1 (hr) Uporaba ulipristala za lijeäśenje uterinih fibroida
HRP20121034T1 (hr) Lijeäśenje upalnih bolesti
AR059330A1 (es) Composiciones acondicionadoras del cabello
BRPI0811948A2 (pt) Novo agente para a liberação de princípios ativos em curativos que contenham ao menos uma susbtância gordurosa
AR064149A1 (es) Sal fumarato de (alfa s , beta r)-6 bromo- alfa-[ 2(dimetilamino ) etil)-2- metoxi - alfa-1-naftalenil- beta- fenil-3- quinolinaetanol
DE602008000786D1 (de) 1,2,4,5-Tetrahydro-3H-Benzazepinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
BRPI0715173A8 (pt) Uso de uma composição de perfume para inibição da formação de amônia a partir da uréia
HRP20221427T1 (hr) Kompozicije i postupci za liječenje rana
HRP20200142T4 (hr) Postupci i sastavi za liječenje depresije uporabom ciklobenzaprina
BR9612213A (pt) Composição farmaceutica oralmente liberada modificada contendo 5-asa e método para o tratamento de doenças do instetino.
CO5160296A1 (es) Nuevas formas de presentacion para agentes activos labiles en medio acido, unidad de agente activo y proceso para la produccion de dicha unidad de agente
ECSP034470A (es) 6.alfa.,9.alfa-difluor-17.alfa.- (2-furanilcarboxilo) oxy-11.beta.-hidroxi-16.alfa.-metil-3-oxo-androst-1,4,-diene-17-acido carbotiotico s-fluormetil ester como un agente anti-inflamatorio
BR0315836A (pt) Derivados de [6,7-dihidro-5h-imidazol[1,2-alfa]imadazol-3-sulfonila mino]-propionamida, composição farmacêutica, uso do mesmo, bem como processo para sua preparação
DE602005002647D1 (de) Hexensäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und therapeutische anwendungen davon